New MDMA and Psilocybin prescription rules
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 7:28 — 10.3MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
The Therapeutic Goods Administration shocked the health sector earlier this year when it announced that from 1 July, authorised psychiatrists would be able to prescribe MDMA to assist treatment of post-traumatic stress disorder, and psilocybin, the active ingredient in magic mushrooms, for treatment-resistant depression.
Guest: Professor Susan Rossell – Cognitive Neuropsychologist and Professorial Research Fellow, Swinburne Centre for Mental Health
Presenter: Warren Andrew
Podcast: Play in new window | Download (Duration: 7:28 — 10.3MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Dr Sam Arnold: Autistic Burnout
Autistic burnout is not just tiredness. It can be a prolonged, life-altering depletion linked to sensory overload and masking. Sam ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 10:10 — 14.0MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Associate Professor Lauren Rosewarne: Why Libraries Are Booming Again
Libraries are busier than they have been in years, and they are no longer just about books. Associate Professor Lauren ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 15:21 — 21.1MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Tomáš Kantor: SUGAR at the 2026 Midsumma Festival
SUGAR is a bold one-person show about desire, money and pop culture fantasies, where glamour and pop songs sit alongside ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 8:51 — 12.2MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS